Skip Navigation
Find a Doctor
 
 
 
 

 

Photo of Dr. Tamara Levin Lotan, MD

Tamara Levin Lotan, MD

Associate Professor of Pathology
Female
Appointment Phone

410-955-2660

Main Location

The Johns Hopkins Hospital

View All Locations
Out-of-State & International Patients +
Out of State Patients

Call 410-464-6641 (8a.m. to 6p.m., EST, Mon-Fri)

Learn more about our out-of-state patient services »

International Patients

Call +1-410-502-0773 (7a.m. to 6p.m., EST, Mon-Fri)

Learn more about our international patient services »

Titles

  • Associate Professor of Pathology
  • Associate Professor of Oncology

Centers & Institutes

  • Cell Dynamics, Center for
  • Institute for Basic Biomedical Sciences

Expertise

Pathology, Prostate Cancer

Research Interests

Prostate cancer; Bladder cancer

Biography

Dr. Tamara Lotan is an associate professor of pathology and oncology at the Johns Hopkins University School of Medicine. Her area of clinical expertise is urologic pathology.

Dr. Lotan received her medical degree from the University of Chicago Pritzker School of Medicine. She completed her residency in anatomic pathology at the University of Chicago Hospitals and performed a fellowship in urology there as well as a fellowship in pathology at the Johns Hopkins University School of Medicine.

She is a urologic pathologist who studies how oncogenic signaling pathways regulate epithelial morphogenesis during embryonic development and tumorigenesis. She has a particular interest in prostate cancer.

Dr. Lotan was recognized by the Prostate Cancer Foundation with the 2011 Elaine Wynn – PCF Young Investigator Award. She is a member of the United States and Canadian Academy of Pathology, the College of American Pathology, and the International Society of Urologic Pathology.

Languages

  • English

Memberships

United States and Canadian Academy of Pathology

College of American Pathology

International Society of Urologic Pathology

Additional Resources

Additional Resources +
  • Education +

    Training

    • University of Chicago Pritzker School of Medicine (Chicago IL) (2003)

    Residencies

    • University of Chicago Hospitals / Anatomic Pathology (Chicago IL) (2007)
    • University of Chicago Hospitals / Anatomic Pathology (Chicago IL) (2005)

    Fellowships

    • Johns Hopkins University School of Medicine / Pathology (Baltimore MD) (2008)
    • University of Chicago Hospitals / Urology (Chicago IL) (2006)

    Certifications

    • American Board of Pathology / Anatomic Pathology (2007)
  • Research & Publications +

    Research Summary

    Dr. Tamara Lotan is a urologic pathologist who studies how oncogenic signaling pathways regulate epithelial morphogenesis during embryonic development and tumorigenesis. Using novel transgenic mouse models combined with 3-D culture and state-of-the-art time-lapse imaging techniques, Dr. Lotan is defining the roles of these critical signals in prostate and mammary epithelial migration and polarity.

    Selected Publications

    1. Lotan TL, Lyon M, Huo D, Taxy JB, Brendler C, Foster B, Stadler W, Rinker-Schaeffer CW. Upregulation of MKK4, MKK6 and MKK7 during Prostate Cancer Progression: An Important Role for SAPK Signaling in Prostatic Neoplasia. Journal of Pathology 2007; 212(4):386-394.
    2. Lotan TL, Tefs K, Schuster V, Miller JL, Manaligod J, Filstead A, Yamada D, Krausz T. Inherited Plasminogen Deficiency Presenting as Ligneous Vaginitis: A Case Report with Molecular Correlation and Review of the Literature. Human Pathology 2007; 38(10):1569-1575.
    3. Lotan TL, Hickson J, Souris J, Huo D, Taylor J, Li T, Otto K, Yamada SD, Macleod K, Rinker-Schaeffer CW. Taylor J, Otto K. Suppression of Ovarian Cancer Metastatic Colonization by JNKK1/MKK4 is Associated with Cellular Growth Arrest and Upregulation of p21. Cancer Research 2008; 68(7):2166-75.
    4. Lotan TL and Epstein JI. Diffuse Adenosis of the Prostate Peripheral Zone in Needle Biopsy and Prostatectomy Specimens. American Journal of Surgical Pathology 2008; 32(9):1360-6.
    5. Lotan TL and Epstein JI. Gleason Grading of Prostatic Adenocarcinoma with Glomeruloid Features on Needle Biopsy. Human Pathology 2008, in press.
    6. Lotan TL, Ye H, Melamed J, Wu XR, Shih IeM and Epstein JI. “An Immunohistochemical Panel to Identify the Primary Site of Invasive Micropapillary Carcinoma.” Am J Surg Pathol. 2009 Jul;33(7):1037-41. doi: 10.1097/PAS.0b013e3181962dcd.
    7. Lotan TL, Toubaji A, Albadine R, Latour M, Herawi M, Meeker M, Epstein JI and Netto GJ. “TMPRSS2-ERG Gene Fusions are Infrequent in Prostatic Ductal Adenocarcinomas.” Modern Pathology. (2009) 22, 359–365; doi:10.1038/modpathol.2008.236. Epub 16 January 2009.
    8. Lotan TL, Wang W,Gupta NS, Toubaji A, Haffner MC, Meeker AK, De Marzo AM, Epstein JI, and Netto GJ. “ERG Gene Rearrangements are Common in Prostatic Small Cell Carcinoma.” Modern Pathology. 2011; 24(6):820-8. doi: 10.1038/modpathol.2011.7. Epub 2011 Feb 18.
    9. Lotan TL, Gurel B, Sutcliffe S, Esopi D, Liu W, Xu J, Hicks JL, Park BH, Humphreys E, Partin AW, Han M, Netto GJ, Isaacs WB, De Marzo AM. “PTEN Protein Loss by Immunostaining: Analytic Validation and Prognostic Indicator for a High Risk Surgical Cohort of Prostate Cancer Patients.” Clinical Cancer Research. 2011; 17(20):6563-73. doi: 10.1158/1078-0432.CCR-11-1244. Epub 2011 Aug 30.
    10. Ghosh S, Lau H, Simons BW, Powell JD, Meyers DJ, De Marzo AM, Berman DM, Lotan TL. “PI3K/mTOR Signaling Regulates Prostatic Branching Morphogenesis.” Developmental Biology. 2011; 360(2):329-42. doi: 10.1016/j.ydbio.2011.09.027. Epub 2011 Oct 8.

    Lab

    Dr. Lotan’s research laboratory focuses on the role of PTEN/PI3K/mTOR signaling in epithelial development and tumorigenesis. Her basic science lab works with a number of epithelial systems (prostate, breast and skin) and is principally interested in understanding how these oncogenic signaling pathways regulate epithelial differentiation, apico-basal polarity, and cell migration. Using transgenic mouse models combined with 3-D culture and state-of-the-art live cell imaging techniques, the hope is that by understanding the role of this signal transduction network in epithelial embryonic development, they can help to elucidate the significance of these oncogenic signals during tumorigenesis and tumor progression.

    The translational side of Dr. Lotan’s laboratory effort is focused on validating PTEN as a potential predictive and prognostic biomarker in prostate cancer and on defining alternative mechanisms of PTEN inactivation in prostate cancer. There is also ongoing interest in the molecular phenotype of rare subtypes of prostate cancer, including small cell carcinoma, p63-positive prostatic carcinoma and intraductal prostatic carcinoma.

  • Academic Affiliations & Courses +
  • Activities & Honors +

    Honors

    The 2011 Elaine Wynn – PCF Young Investigator Award, 2011

  • Videos & Media +
  • Events +
  • Contact & Locations +

    Locations

    The Johns Hopkins Hospital
    600 N. Wolfe Street
    Hospital Main Entrance - Sheikh Zayed Tower
    Baltimore, MD 21287
    Phone: 410-614-9196
    Appointment Phone: 410-955-2660
    Location Map
    Johns Hopkins Bayview Medical Center
    4940 Eastern Avenue
    Baltimore, MD 21224
    Appointment Phone: 410-955-2660
    Location Map
    Johns Hopkins Outpatient Center
    601 N. Caroline Street
    Baltimore, MD 21287
    Appointment Phone: 410-955-2600
    Location Map
    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
    401 N. Broadway
    Baltimore, MD 21231
    Appointment Phone: 410-955-2600
    Fax: 410-502-9911
    Location Map

    Department/Division

    • Pathology

Is This You? Edit Profile

 
 
 
 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.

Privacy Policy and Disclaimer